Cormorant Asset Management »

Crinetics Pharmaceuticals In shares owned by Cormorant Asset Management

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Cormorant Asset Management from 13F filings

Historical chart of Cormorant Asset Management investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Cormorant Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Cormorant Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $61M 1.4M 44.79
2024-03-31 $54M 1.2M 46.81
2023-12-31 $41M 1.2M 35.58
2023-09-30 $33M 1.1M 29.74